site map
contact
advanced search
home
news
treatment & care
hiv worldwide
living with hiv
preventing hiv
organisations
hiv basics
about us
Aidsmap
hepatitis news
Russian
Français
Português
Español
YOU ARE HERE:
> home
>
> Key topic guides
>>
> News categories
Hepatitis news
page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
of 14
next
Headline
Date
Hepatitis B co-infection doesn't affect response to HIV treatment
25.06.09
New hepatitis C drug may halve the length of treatment, but ribavirin still needed
12.06.09
Hepatitis C increases risk of cardiovascular disease
12.06.09
Should we spare the nukes? NRTI HIV drugs may impair success of hepatitis C treatment
08.06.09
Hepatitis B hasn’t gone away – and may come back
08.06.09
Hepatitis B may increase all-cause mortality in HIV-positive people, according to meta-analysis
03.06.09
HIV treatment reduces liver damage in HIV/HCV co-infected patients
07.05.09
Hepatitis C has no impact on CD4 cell recovery in patients taking HIV treatment
27.03.09
HIV treatment is not the cause of cryptogenic liver disease
27.03.09
Conference highlights the forces encouraging risk behaviour in gay men
13.03.09
Continuous antiretroviral therapy improves survival in HIV/hepatitis C co-infected patients with liver cirrhosis
04.03.09
High hepatitis C viral load increases risk of death in HIV/HCV co-infected patients
02.03.09
Hepatitis C in HIV-positive gay men: Amsterdam, Paris, New York and UK compared
17.02.09
Tenofovir provides good hepatitis B virus suppression in HIV/HBV co-infected patients
16.02.09
Hospitalisation and disability are higher amongst HIV patients with hepatitis C coinfection
11.02.09
Half of HIV/HCV co-infected early responders are cured with 72-week treatment
11.02.09
Hepatitis C: high rate of treatment success in recently infected HIV positive gay men
06.02.09
Weak immune system may explain increased risk of death seen in HIV/hepatitis C co-infected patients
29.01.09
Study supports early initiation of HIV treatment by HIV/hepatitis C co-infected patients
29.01.09
Atazanavir-treated patients have increased risk of hyperbilirubinaemia after starting therapy for hepatitis C
08.12.08
aidsmap links
Hepatitis
Adefovir - key research
Adefovir - overview
Bareback hep C risk
Elvucitabine
Hepatitis
Hepatitis
Hepatitis B
Hepatitis B
Hepatitis C
Hepatitis C - key research
Hepatitis C - overview
Interferon alfa
NICE approves pegylated interferon for hepatitis C
Racivir
Ribavirin
The Liver
UK trials in HIV/hepatitis co-infection
UK trials in HIV/hepatitis co-infection
subscribe to aidsmap email bulletins
page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
of 14
next
key topic guides
Key topic guides
News categories
Links categories
other news categories
latest news
Adherence news
Africa news
AIDS funding news
Asia and Pacific news
Basic science news
Changing treatments news
Children and HIV news
Circumcision news
Community involvement news
Conference news
Developed world news
Eastern Europe and Russia news
Gay men news
Hepatitis news
HIV and cancer news
HIV and drug use news
HIV and sexual health news
HIV and the law news
HSV-2
Latin America news
Lipodystrophy news
Medical tests news
Mental health news
Microbicides news
Middle East news
Mother-to-child transmission news
New drugs news
News Features
Palliative care news
Pharmacokinetics news
Prevention news
Resistance news
Salvage treatment news
Side-effects news
Starting treatment news
Statistics and epidemiology news
Treatment access news
Treatment interruptions news
Tuberculosis news
UK news
Vaccines news
Women and HIV news
World policy News
Support our work today